Iambic is a clinical-stage biotech using AI to compress drug discovery timelines. The stack reveals dual operations: a Python-centric ML pipeline (PyTorch, Hugging Face, Databricks, Airflow) for AI model development, paired with wet-lab automation (HPLC, qPCR, Agilent) and structured clinical workflows (Veeva, NetSuite). Leadership-heavy hiring (12 senior, 5 director roles in 21 open positions) underscores the company's shift from research stage toward clinical execution—matching their active focus on IND submissions, clinical documentation, and scaled compute infrastructure.
Notable leadership hires: DMPK Director
Iambic develops novel drug candidates using a proprietary AI platform, moving molecules from discovery to human clinical trials. The company merges computational drug design (Python, PyTorch, large language models) with experimental validation (HPLC, qPCR, automated purification workflows), targeting multiple therapeutic mechanisms and disease areas. Based in San Diego with 51–200 employees, Iambic is operationally bridging research and clinic: the platform stack includes Veeva for regulatory submissions, NetSuite for resource planning, and Databricks for ML at scale. Current bottlenecks center on compute scaling for discovery simulations, purification throughput, and managing complex document workflows tied to IND and clinical-stage submissions.
Iambic uses Python, PyTorch, and Hugging Face for ML; Databricks and Apache Spark for data; Airflow and Prefect for workflow orchestration; AWS, Azure, GCP, and Kubernetes for cloud infrastructure; and Veeva and NetSuite for regulatory and business operations.
San Diego, California. The company is actively hiring in the United States and Germany.
Iambic Therapeutics's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.